- Home
- WST vs XPEV Comparison
WST vs XPEV Comparison
Compare WST & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- XPEV
- Stock Information
- Founded
- WST 1923
- XPEV 2015
- Country
- WST United States
- XPEV China
- Employees
- WST N/A
- XPEV N/A
- Industry
- WST Medical/Dental Instruments
- XPEV Auto Manufacturing
- Sector
- WST Health Care
- XPEV Consumer Discretionary
- Exchange
- WST Nasdaq
- XPEV Nasdaq
- Market Cap
- WST 20.1B
- XPEV 21.7B
- IPO Year
- WST N/A
- XPEV 2020
- Fundamental
- Price
- WST $267.69
- XPEV $26.54
- Analyst Decision
- WST Strong Buy
- XPEV Buy
- Analyst Count
- WST 9
- XPEV 8
- Target Price
- WST $354.50
- XPEV $22.51
- AVG Volume (30 Days)
- WST 777.9K
- XPEV 14.4M
- Earning Date
- WST 10-23-2025
- XPEV 11-17-2025
- Dividend Yield
- WST 0.33%
- XPEV N/A
- EPS Growth
- WST 0.17
- XPEV N/A
- EPS
- WST 6.75
- XPEV N/A
- Revenue
- WST $3,017,900,000.00
- XPEV $8,416,181,216.00
- Revenue This Year
- WST $6.97
- XPEV $99.25
- Revenue Next Year
- WST $6.11
- XPEV $39.50
- P/E Ratio
- WST $39.50
- XPEV N/A
- Revenue Growth
- WST 4.92
- XPEV 66.37
- 52 Week Low
- WST $187.43
- XPEV $11.14
- 52 Week High
- WST $348.90
- XPEV $28.24
- Technical
- Relative Strength Index (RSI)
- WST 44.02
- XPEV 61.77
- Support Level
- WST $262.48
- XPEV $21.60
- Resistance Level
- WST $280.11
- XPEV $28.20
- Average True Range (ATR)
- WST 9.93
- XPEV 1.30
- MACD
- WST -2.47
- XPEV 0.48
- Stochastic Oscillator
- WST 12.37
- XPEV 75.02
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.